Table 2.
The relationship between the expression level of lnc HOTAIR and characteristics of newly diagnosed MM
| Characteristics | Number (n = 24) | Relative expression of HOTAIR Mean ± SD | P value |
|---|---|---|---|
| Age (years) | |||
| < 65 | 22 | 3.06 ± 1.43 | 0.652 |
| ≥ 65 | 2 | 3.86 ± 2.47 | |
| Gender | |||
| Male | 16 | 3.13 ± 1.34 | 0.569 |
| Female | 8 | 3.12 ± 1.82 | |
| Ig isotype | |||
| IgG | 18 | 3.34 ± 1.49 | 0.069 |
| IgA | 3 | 1.63 ± 0.64 | |
| LC | 3 | 3.37 ± 1.41 | |
| Hemoglobin (g/L) | |||
| < 100 | 20 | 3.33 ± 1.54 | 0.08 |
| ≥ 100 | 4 | 2.13 ± 0.33 | |
| B2-Micro globulin (mg/L) | |||
| < 3.5 | 8 | 2.24 ± 0.78 | 0.087 |
| ≥ 3.5 | 16 | 3.58 ± 1.56 | |
| Albumin (g/L) | |||
| < 35 | 14 | 3.47 ± 1.46 | 0.096 |
| ≥ 35 | 10 | 2.65 ± 1.43 | |
| Creatinine (μmol/L) | |||
| < 177 | 15 | 2.93 ± 1.32 | 0.640 |
| ≥ 177 | 9 | 3.45 ± 1.74 | |
| Calcium (mmol/L) | |||
| < 2.65 | 15 | 2.73 ± 1.20 | 0.215 |
| ≥ 2.65 | 9 | 3.79 ± 1.72 | |
| Myeloma cells in BM (%)a | |||
| < 48 | 12 | 2.29 ± 0.67 | 0.006* |
| ≥ 48 | 12 | 3.97 ± 1.60 | |
| Bone disease | |||
| Absent | 9 | 2.78 ± 0.93 | 0.599 |
| Present | 15 | 3.34 ± 2.83 | |
| D–S stage | |||
| I | 3 | 2.21 ± 0.36 | 0.160 |
| II | 7 | 2.53 ± 1.19 | |
| III | 14 | 3.62 ± 1.59 | |
| ISS stage | |||
| I | 5 | 1.85 ± 0.58 | 0.031* |
| II | 10 | 3.06 ± 1.17 | |
| III | 9 | 3.91 ± 1.69 |
D-S Durie–Salmon, ISS International Staging System, BM bone marrow, LC light chain, SD standard deviation
*Statistically significant at P < 0.05
a48% is the mean value of the percentage of myeloma cells in BM of 24 MM patients